Verve Therapeutics
VERV
#6544
Rank
NZ$0.89 B
Marketcap
$10.57
Share price
-0.79%
Change (1 day)
-62.71%
Change (1 year)

Verve Therapeutics (VERV) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$0.25 Billion

According to Verve Therapeutics's latest financial reports the company's total liabilities are NZ$0.25 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Verve Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$0.24 B19.88%
2022-12-31NZ$0.20 B415.53%
2021-12-31NZ$39.19 M-80.13%
2020-12-31NZ$0.19 B222.43%
2019-12-31NZ$61.17 M